Core Viewpoint - Amesite Inc. intends to conduct a public offering of its common stock or pre-funded warrants, subject to market conditions, with no assurance on the timing or terms of the offering [1]. Group 1: Offering Details - The offering will be managed by Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC as joint book-running managers [2]. - The net proceeds from the offering will be utilized for general corporate purposes, capital expenditures, working capital, and general and administrative expenses [2]. - A shelf registration statement related to the public offering was filed with the SEC and declared effective on December 18, 2024 [3]. Group 2: Company Overview - Amesite Inc. specializes in developing and marketing AI-driven solutions for both B2C and B2B markets [5]. - The company offers applications that cater to individual and professional needs, including NurseMagic™, a mobile app designed for health and care professionals to streamline nursing documentation and enhance patient communication [5].

Core Insights - Amesite Inc. is set to present its growth strategy for NurseMagic, targeting both B2C and B2B users across 50 states and 21 countries, covering 87 professions [1][3][4] - The presentation will take place at the Sidoti January Virtual Investor Conference on January 22-23, 2025, with live access available through Amesite's website [2] Company Overview - Amesite Inc. specializes in AI-driven solutions for B2C and B2B markets, including a mobile app called NurseMagic that enhances healthcare professionals' efficiency [5] - NurseMagic supports a wide range of healthcare professionals, including registered nurses, physicians, EMTs, and healthcare executives, demonstrating significant user growth since its launch [3][5] Sales and Market Potential - The company has reported strong enterprise sales, particularly among franchisees of major home care providers, indicating a robust market response to NurseMagic [4] - Amesite's CEO highlighted the potential for sustainable revenue growth due to the efficiency improvements NurseMagic offers in healthcare settings [4]

Presentation Includes Discussion of Monetization of NurseMagic™ DETROIT, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today it will release an end of year video shareholder update to its website today, December 23, 2024 at 3:00 pm ET. The presentation will be available to shareholders here: https://ir.amesite.com/news-events/media. As part of the update, Amesite's CEO ...

Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in HealthcareDETROIT, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), creator of the AI-powered NurseMagic™ app, announces significant marketing growth alongside its enterprise and consumer sales success. NurseMagic™ harnesses advanced AI to provide intelligent, real-time support for caregivers, transforming how care is delivered and managed. By building B2B and B2C visibility in par ...

DETROIT, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ:AMST), creator of the NurseMagic™ app, has closed on contracts with franchise owners representing nationally recognized brands that operate hundreds of locations across the country. These initial contract wins represent a major milestone for NurseMagic™, proving its value as a repeatable, scalable solution for franchise businesses. By addressing critical challenges in workforce performance and engagement, NurseMagic™ delivers immediate ROI with ...

DETROIT, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading technology company specializing in AI-driven solutions for B2C and B2B markets, announced today the company’s app, NurseMagic™, is now available for direct subscription purchases by consumers. NurseMagic™ has seen strong user growth since its launch this summer and now supports users from eighty-seven (87) professions (ranging from registered nurses, to physicians, EMTs, occupational therapists, hospital managers, healthcare C ...

[PART I – FINANCIAL INFORMATION](index=5&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) Unaudited Q3 2024 financial statements, management's analysis, and disclosures, noting net losses and going concern doubts - Amesite Inc. specializes in B2C and B2B AI-driven solutions, including a higher education platform and the NurseMagic™ mobile healthcare app[22](index=22&type=chunk) - The company has a history of net losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern[27](index=27&type=chunk)[30](index=30&type=chunk) - Management plans to generate cash through financing transactions, such as common stock offerings, but these are not guaranteed[30](index=30&type=chunk) [ITEM 1. FINANCIAL STATEMENTS](index=5&type=section&id=ITEM%201.%20FINANCIAL%20STATEMENTS) Presents unaudited Q3 2024 and 2023 condensed financial statements, including balance sheets, operations, equity, cash flows, and notes - The financial statements are unaudited and prepared in accordance with GAAP and SEC requirements[23](index=23&type=chunk)[24](index=24&type=chunk) - Interim results are not necessarily indicative of results for a full year[24](index=24&type=chunk) [Condensed Balance Sheets (unaudited)](index=8&type=section&id=Condensed%20Balance%20Sheets%20(unaudited)) Balance sheets show slight decreases in total assets and equity, increased current liabilities, and a significant drop in cash from June to September 2024 Condensed Balance Sheet Highlights (Unaudited) | Metric | September 30, 2024 | June 30, 2024 | Change (Absolute) | Change (%) | | :-------------------------- | :----------------- | :------------ | :---------------- | :--------- | | Cash and cash equivalents | $1,434,753 | $2,071,016 | $(636,263) | -30.72% | | Total current assets | $2,496,774 | $2,604,565 | $(107,791) | -4.14% | | Total noncurrent assets | $739,336 | $709,612 | $29,724 | 4.19% | | Total assets | $3,236,110 | $3,314,177 | $(78,067) | -2.36% | | Total current liabilities | $843,003 | $798,465 | $44,538 | 5.58% | | Total stockholders' equity | $2,393,107 | $2,515,712 | $(122,605) | -4.87% | [Condensed Statements of Operations (unaudited)](index=9&type=section&id=Condensed%20Statements%20of%20Operations%20(unaudited)) Operations statements show a significant revenue decrease for Q3 2024, leading to a slightly higher net loss despite reduced operating expenses Condensed Statements of Operations Highlights (Unaudited) | Metric | Three Months Ended Sep 30, 2024 | Three Months Ended Sep 30, 2023 | Change (Absolute) | Change (%) | | :-------------------------- | :------------------------------ | :------------------------------ | :---------------- | :--------- | | Net Revenue | $11,250 | $63,333 | $(52,083) | -82.24% | | Total Operating Expenses | $938,594 | $1,013,323 | $(74,729) | -7.37% | | Loss from Operations | $(927,344) | $(949,990) | $22,646 | -2.38% | | Interest Income | $19,299 | $59,297 | $(39,998) | -67.46% | | Net Loss | $(908,045) | $(890,693) | $(17,352) | 1.95% | | Basic and diluted loss per share | $(0.34) | $(0.35) | $0.01 | -2.86% | | Weighted average shares outstanding | 2,707,275 | 2,542,440 | 164,835 | 6.48% | [Condensed Statements of Stockholders' Equity (unaudited)](index=10&type=section&id=Condensed%20Statements%20of%20Stockholders'%20Equity%20(unaudited)) Stockholders' equity decreased from July 1 to September 30, 2024, primarily due to net loss, partially offset by stock issuance and compensation - Total stockholders' equity decreased from **$2,515,712** on July 1, 2024, to **$2,393,107** on September 30, 2024[18](index=18&type=chunk) - Net loss of **$(908,045)** contributed to the decrease in equity[18](index=18&type=chunk) - Issuance of **250,000 common shares** for consulting services added **$720,000** to additional paid-in capital[18](index=18&type=chunk) - Stock-based compensation expense was **$65,440** for the quarter[18](index=18&type=chunk) [Condensed Statements of Cash Flows (unaudited)](index=11&type=section&id=Condensed%20Statements%20of%20Cash%20Flows%20(unaudited)) Cash flows show a net decrease in cash for Q3 2024, driven by operating and investing activities, including significant capitalized software investment Condensed Statements of Cash Flows Highlights (Unaudited) | Metric | Three Months Ended Sep 30, 2024 | Three Months Ended Sep 30, 2023 | Change (Absolute) | Change (%) | | :------------------------------------------ | :------------------------------ | :------------------------------ | :---------------- | :--------- | | Net cash used in operating activities | $(488,263) | $(658,779) | $170,516 | -25.88% | | Net cash used in investing activities | $(148,000) | $(65,200) | $(82,800) | 127.00% | | Net decrease in cash and cash equivalents | $(636,263) | $(723,979) | $87,716 | -12.11% | | Cash and cash equivalents - End of period | $1,434,753 | $4,636,682 | $(3,201,929) | -69.05% | [Notes to Condensed Financial Statements (unaudited)](index=12&type=section&id=Notes%20to%20Condensed%20Financial%20Statements%20(unaudited)) These notes detail business operations, accounting policies, and financial items, reiterating liquidity concerns and going concern uncertainty - Financial statements are prepared in accordance with GAAP and SEC requirements, with certain disclosures condensed or omitted[23](index=23&type=chunk)[25](index=25&type=chunk) - The company's ability to continue as a going concern is uncertain due to historical losses and negative cash flows[26](index=26&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk)[30](index=30&type=chunk) [Note 1 - Nature of Business and Liquidity](index=12&type=section&id=Note%201%20-%20Nature%20of%20Business%20and%20Liquidity) Amesite Inc. develops AI-driven solutions but faces liquidity challenges, with ongoing net losses raising substantial doubt about its going concern ability - Amesite Inc. develops and markets B2C and B2B AI-driven solutions, including a higher education platform and the NurseMagic™ mobile healthcare app[22](index=22&type=chunk) - The company has a history of net losses and negative cash flows from operating activities since inception[27](index=27&type=chunk) - Management believes it may not have sufficient cash for planned operations for the next twelve months, raising substantial doubt about its going concern ability[28](index=28&type=chunk) [Note 2 - Significant Accounting Policies](index=12&type=section&id=Note%202%20-%20Significant%20Accounting%20Policies) This note outlines accounting principles, including basis of presentation, going concern, estimates, and policies for cash, property, software, revenue, and taxes [Basis of Presentation](index=12&type=section&id=Basis%20of%20Presentation) Condensed financial statements adhere to GAAP and SEC requirements, with interim results not necessarily indicative of full-year performance - Statements adhere to GAAP and SEC rules[23](index=23&type=chunk) - Interim results may not predict full-year outcomes[24](index=24&type=chunk) [Going Concern](index=12&type=section&id=Going%20Concern) The company's history of net losses and negative cash flows raises substantial doubt about its ability to continue as a going concern, with financing plans uncertain - History of net losses and negative operating cash flows[27](index=27&type=chunk) - Substantial doubt exists regarding the company's ability to continue as a going concern[30](index=30&type=chunk) - Management plans to seek financing, but success is not assured[30](index=30&type=chunk) [Use of Estimates](index=13&type=section&id=Use%20of%20Estimates) Financial statements rely on management's estimates and assumptions, and actual results may differ from these projections - Financial statements rely on management estimates and assumptions[31](index=31&type=chunk) - Actual results could vary from estimates[31](index=31&type=chunk) [Cash and Cash Equivalents](index=13&type=section&id=Cash%20and%20Cash%20Equivalents) Cash equivalents include short-term investments, with the company

Company Overview - Amesite Inc. is a technology company focused on AI-driven solutions for both B2C and B2B markets, recently generating revenue in the home care market [1][6]. Industry Insights - The home care sector faces critical challenges such as staff turnover, documentation requirements, and operational costs, with approximately 77% of home care clients in the U.S. being turned away due to workforce and resource limitations [2]. - There are about 33,000 home care and hospice organizations in the U.S., employing roughly 1.4 million workers in 2023 [3]. - The aging population in the U.S. is projected to increase the demand for home-based elder care significantly, with the number of Americans living with Alzheimer's disease expected to rise from 6 million today to over 13 million by 2050 [3]. Company Solutions - Amesite's AI platform provides real-time support for all levels of staff in home care agencies, enhancing workflow efficiency and employee retention by reducing administrative burdens [5]. - The company claims to deliver a 15X return on investment (ROI) for its solutions, with significant interest from independently-owned agencies and franchisees participating in pilot agreements [4]. Market Potential - The urgent need for growth in the home care sector is constrained by workforce shortages and high operational costs, making AI-driven efficiency tools essential [3][5]. - The transition from pilot phases to trial usage of Amesite's solutions indicates a strong market interest and potential for broader corporate adoption [4].

DETROIT, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today its Founder and CEO, Dr. Ann Marie Sastry, was featured as a guest speaker at the Lesher Foundation's Newsmakers: 24/25 Season on October 24, 2024, following Former U.S. Representative Liz Cheney, Former World #1 Tennis Player and Founder of Chris Evert Charities, Chris Evert, Host of CNN's Smerconish and Bes ...

DETROIT, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today the company’s app, NurseMagic, enables multiple professions to use the app with customized features for each. Enterprises can now deliver tailored features to employees across different professions using a single solution, with a paid subscription. Enterprise employees currently using NurseMagic™ range from C ...